Latest news for GBX Intl Gr (OTC:GBXI) Stock

GBX International Group Inc is a marketing and customer acquisition company. It provides local merchants, entrepreneurs, and charities with a unique marketing and advertising system that includes online tools, marketing materials and expertise that can help merchants and charities increase their customer bases, develop more repeat customers and expand their buying and giving communities. The company also offers local merchants discounted credit and debit card processing services provided by third party processors and earns income on ongoing transactions occurring at those locations.

GBX INTERNATIONAL GROUP by GBX International Group Inc.

GBX International Group Inc

4 analysts have expressed a variety of opinions on Camping World Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWH#NYSE">CWH</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $26.25, with a high estimate of $28.00 and a low estimate of $25.00. This current average has decreased by 2.78% from the previous average price target of $27.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1726844468_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Camping World Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$28.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Scott Stember</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Buy</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Noah Zatzkin</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Camping World Holdings. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Camping World Holdings compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Camping World Holdings's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CWH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Camping World Holdings analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Camping World Holdings</h2>
Camping World Holdings Inc is retailer of RVs and related products and services. The Company has the two reportable segments: Good Sam Services and Plans segment includes sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories. RV and Outdoor Retail segment includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, sale of outdoor products, equipment, gear and supplies; business to business distribution of RV furniture, etc.
<h3>Camping World Holdings: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Camping World Holdings's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -4.96%. This indicates a decrease in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Camping World Holdings's net margin excels beyond industry benchmarks, reaching 0.54%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Camping World Holdings's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.54% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Camping World Holdings's ROA stands out, surpassing industry averages. With an impressive ROA of 0.2%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Camping World Holdings's debt-to-equity ratio is notably higher than the industry average. With a ratio of 36.45, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Landscape: 4 Takes On Camping World Holdings

Octavio Espinoza, Chief Financial Officer at Ligand Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGND#NASDAQ">LGND</a>), reported a large exercise of company stock options on September 19, according to a new SEC filing.
What Happened: Espinoza, Chief Financial Officer at Ligand Pharmaceuticals, made a strategic move by exercising stock options for 1,486 shares of LGND as detailed in a Form 4 filing on Thursday with the <a href="https://www.sec.gov/Archives/edgar/data/0000886163/000200101124000084//Archives/edgar/data/886163/000200101124000084/0002001011-24-000084-index.htm">U.S. Securities and Exchange Commission</a>. The transaction value amounted to $36,527.
Currently, Ligand Pharmaceuticals shares are trading down 0.76%, priced at $104.21 during Friday's morning. This values Espinoza's 1,486 shares at $36,527.
<h3>Unveiling the Story Behind Ligand Pharmaceuticals</h3>
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
<h3>Ligand Pharmaceuticals's Financial Performance</h3>
Revenue Growth: Ligand Pharmaceuticals's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 57.52%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 93.0%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Ligand Pharmaceuticals's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of -2.88.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 45.07 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 14.14 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Ligand Pharmaceuticals's EV/EBITDA ratio stands at 19.13, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Cracking Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000886163">Check Out The Full List Of Ligand Pharmaceuticals's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Trading Ideas

LGND

Breaking Update: Octavio Espinoza Engages In Options Exercise At Ligand Pharmaceuticals

In a new SEC filing on September 20, it was revealed that TaylorSimpson, Chief Financial Officer at A-Mark Precious Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRK#NASDAQ">AMRK</a>), executed a significant exercise of company stock options.
What Happened: TaylorSimpson, Chief Financial Officer at A-Mark Precious Metals, made a strategic move by exercising stock options for 25,000 shares of AMRK as detailed in a Form 4 filing on Friday with the <a href="https://www.sec.gov/Archives/edgar/data/0001591588/000159396824001211//Archives/edgar/data/1591588/000159396824001211/0001593968-24-001211-index.htm">U.S. Securities and Exchange Commission</a>. The transaction value amounted to $1,015,699.
A-Mark Precious Metals shares are trading up 0.02% at $43.44 at the time of this writing on Friday morning. Since the current price is $43.44, this makes TaylorSimpson's 25,000 shares worth $1,015,699.
<h3>All You Need to Know About A-Mark Precious Metals</h3>
A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.
<h3>Financial Insights: A-Mark Precious Metals</h3>
Revenue Challenges: A-Mark Precious Metals's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -19.06%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: With a low gross margin of 1.7%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): A-Mark Precious Metals's EPS is below the industry average. The company faced challenges with a current EPS of 1.34. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: A-Mark Precious Metals's debt-to-equity ratio stands notably higher than the industry average, reaching 1.28. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: A-Mark Precious Metals's P/E ratio of 15.3 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 0.11 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 12.89, A-Mark Precious Metals demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>A Deep Dive into Insider Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001591588">Check Out The Full List Of A-Mark Precious Metals's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMRK

Chief Financial Officer At A-Mark Precious Metals Exercises Options Worth $1.02M

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on America Movil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for America Movil, revealing an average target of $19.57, a high estimate of $22.60, and a low estimate of $17.80. Experiencing a 3.12% decline, the current average is now lower than the previous average price target of $20.20. 
<img src="https://www.benzinga.com/files/images/story/2024/1726844455_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of America Movil's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andres Coello</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$17.80</td>
<td>$18.90</td>
</tr>
<tr>
<td>Leonardo Olmos</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$22.60</td>
<td>$23.30</td>
</tr>
<tr>
<td>Andres Coello</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$18.90</td>
<td>$19.00</td>
</tr>
<tr>
<td>Andres Coello</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$19.00</td>
<td>$19.60</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to America Movil. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of America Movil compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of America Movil's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of America Movil's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AMX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on America Movil analyst ratings.</a>
<h2>Unveiling the Story Behind America Movil</h2>
America Movil is the largest telecom carrier in Latin America, serving about 290 million wireless customers across the region. It also provides fixed-line phone, internet access, and television services in most of the countries it serves. Mexico is the firm's largest market, providing about 35% of service revenue. Movil dominates the Mexican wireless market with more than 60% customer share and also serves about half of fixed-line internet access customers in the country. Brazil, its second most important market, provides about 20% of service revenue. Movil sold its low-margin wireless resale business in the US to Verizon in 2021 and now owns a 1.4% stake in the US telecom giant. The firm also holds a 60% stake in Telekom Austria.
<h3>Unraveling the Financial Story of America Movil</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: America Movil's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 1.48%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Communication Services sector.
Net Margin: America Movil's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.53% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): America Movil's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.27% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): America Movil's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.07%, the company showcases efficient use of assets and strong financial health.
Debt Management: America Movil's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.68.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For America Movil

In today's rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to conduct comprehensive company evaluations. In this article, we will undertake an in-depth industry comparison, assessing Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) alongside its primary competitors in the Software industry. By meticulously examining crucial financial indicators, market positioning, and growth potential, we aim to provide valuable insights to investors and shed light on company's performance within the industry.
<h3>Oracle Background</h3>
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Oracle Corp</td>
<td>43.19</td>
<td>42.94</td>
<td>8.81</td>
<td>30.01%</td>
<td>$5.44</td>
<td>$9.4</td>
<td>6.86%</td>
</tr>
<tr>
<td>Microsoft Corp</td>
<td>37.17</td>
<td>12.14</td>
<td>13.36</td>
<td>8.45%</td>
<td>$34.33</td>
<td>$45.04</td>
<td>15.2%</td>
</tr>
<tr>
<td>ServiceNow Inc</td>
<td>166.53</td>
<td>21.84</td>
<td>19.13</td>
<td>3.12%</td>
<td>$0.48</td>
<td>$2.08</td>
<td>22.19%</td>
</tr>
<tr>
<td>Palo Alto Networks Inc</td>
<td>45.82</td>
<td>21.01</td>
<td>14.71</td>
<td>7.42%</td>
<td>$0.39</td>
<td>$1.62</td>
<td>12.09%</td>
</tr>
<tr>
<td>CrowdStrike Holdings Inc</td>
<td>401.83</td>
<td>23.82</td>
<td>19.58</td>
<td>1.75%</td>
<td>$0.12</td>
<td>$0.73</td>
<td>31.74%</td>
</tr>
<tr>
<td>Fortinet Inc</td>
<td>44.77</td>
<td>200.81</td>
<td>10.60</td>
<td>504.05%</td>
<td>$0.5</td>
<td>$1.16</td>
<td>10.95%</td>
</tr>
<tr>
<td>Gen Digital Inc</td>
<td>27.98</td>
<td>8.39</td>
<td>4.47</td>
<td>8.69%</td>
<td>$0.54</td>
<td>$0.78</td>
<td>2.33%</td>
</tr>
<tr>
<td>Monday.Com Ltd</td>
<td>334.34</td>
<td>15.02</td>
<td>16.35</td>
<td>1.62%</td>
<td>$0.0</td>
<td>$0.21</td>
<td>34.4%</td>
</tr>
<tr>
<td>Dolby Laboratories Inc</td>
<td>33.31</td>
<td>2.85</td>
<td>5.63</td>
<td>1.58%</td>
<td>$0.06</td>
<td>$0.25</td>
<td>-3.2%</td>
</tr>
<tr>
<td>CommVault Systems Inc</td>
<td>39.49</td>
<td>23.77</td>
<td>7.98</td>
<td>6.62%</td>
<td>$0.02</td>
<td>$0.18</td>
<td>13.38%</td>
</tr>
<tr>
<td>Qualys Inc</td>
<td>27.22</td>
<td>10.61</td>
<td>7.98</td>
<td>10.52%</td>
<td>$0.05</td>
<td>$0.12</td>
<td>8.38%</td>
</tr>
<tr>
<td>Teradata Corp</td>
<td>45.45</td>
<td>37.27</td>
<td>1.62</td>
<td>57.36%</td>
<td>$0.09</td>
<td>$0.27</td>
<td>-5.63%</td>
</tr>
<tr>
<td>Progress Software Corp</td>
<td>35.37</td>
<td>6.14</td>
<td>3.62</td>
<td>3.75%</td>
<td>$0.05</td>
<td>$0.14</td>
<td>-1.78%</td>
</tr>
<tr>
<td>N-able Inc</td>
<td>72.28</td>
<td>3.33</td>
<td>5.43</td>
<td>1.32%</td>
<td>$0.03</td>
<td>$0.1</td>
<td>12.6%</td>
</tr>
<tr>
<td>SolarWinds Corp</td>
<td>106.92</td>
<td>1.67</td>
<td>2.80</td>
<td>0.86%</td>
<td>$0.07</td>
<td>$0.17</td>
<td>4.44%</td>
</tr>
<tr>
<td>Average</td>
<td>101.32</td>
<td>27.76</td>
<td>9.52</td>
<td>44.08%</td>
<td>$2.62</td>
<td>$3.77</td>
<td>11.22%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By conducting an in-depth analysis of Oracle, we can identify the following trends: 
<ul>
<li>
The Price to Earnings ratio of 43.19 is 0.43x lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
The elevated Price to Book ratio of 42.94 relative to the industry average by 1.55x suggests company might be overvalued based on its book value.
</li>
<li>
The Price to Sales ratio is 8.81, which is 0.93x the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
The Return on Equity (ROE) of 30.01% is 14.07% below the industry average, suggesting potential inefficiency in utilizing equity to generate profits.
</li>
<li>
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $5.44 Billion is 2.08x above the industry average, highlighting stronger profitability and robust cash flow generation.
</li>
<li>
With higher gross profit of $9.4 Billion, which indicates 2.49x above the industry average, the company demonstrates stronger profitability and higher earnings from its core operations.
</li>
<li>
The company is witnessing a substantial decline in revenue growth, with a rate of 6.86% compared to the industry average of 11.22%, which indicates a challenging sales environment.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726844450_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio helps evaluate the capital structure and financial leverage of a company.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
By considering the Debt-to-Equity ratio, Oracle can be compared to its top 4 peers, leading to the following observations:
<ul>
<li>
Among its top 4 peers, Oracle is placed in the middle with a moderate debt-to-equity ratio of 7.81.
</li>
<li>
This implies a balanced financial structure, with a reasonable proportion of debt and equity.
</li>
</ul>
<h3>Key Takeaways</h3>
For Oracle in the Software industry, the PE ratio is low compared to peers, indicating potential undervaluation. The PB ratio is high, suggesting investors are willing to pay a premium for its assets. The PS ratio is low, signaling a possible undervaluation based on revenue. In terms of ROE, Oracle is performing below industry average, while its high EBITDA and gross profit indicate strong operational performance. The low revenue growth may raise concerns about future prospects compared to industry peers.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Markets

ORCL

Inquiry Into Oracle's Competitor Dynamics In Software Industry

HF Sinclair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DINO#NYSE">DINO</a>) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $56.92, a high estimate of $70.00, and a low estimate of $49.00. This current average represents a 6.69% decrease from the previous average price target of $61.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1726844445_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of HF Sinclair by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$49.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$53.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$70.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$53.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$61.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$51.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$59.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$56.00</td>
<td>$60.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to HF Sinclair. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of HF Sinclair compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of HF Sinclair's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into HF Sinclair's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DINO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on HF Sinclair analyst ratings.</a>
<h2>Get to Know HF Sinclair Better</h2>
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.
<h3>HF Sinclair's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: HF Sinclair displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 0.16%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: HF Sinclair's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1.92%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): HF Sinclair's ROE stands out, surpassing industry averages. With an impressive ROE of 1.5%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): HF Sinclair's ROA excels beyond industry benchmarks, reaching 0.86%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.31.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DINO

Cracking The Code: Understanding Analyst Reviews For HF Sinclair

The recent uptick in mining mergers and acquisitions (M&amp;A) is masking the slowdown in greenfield exploration projects. Companies are increasingly relying on acquisitions rather than the expensive and risky process of discovering new deposits.
After making a new all-time high in May, copper has declined and stepped down from the headlines, leaving gold in the top spot. Despite copper's price decline, its looming shortages continue to trouble analysts, who project significant <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40831930/copper-deficit-to-reach-4-million-tons-by-2030-analyst-predicts-mining-electrificat">discrepancies between supply and demand</a> in coming years.
BHP Group Ltd.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>) Oak Dam project in Australia, discovered in 2018, presents one of the few large-scale greenfield copper prospects in development today. The exploration target is an estimated 500 million to 1.7 billion tons of ore with a copper grade of 0.8-1.1%, an exceptionally promising find.
Globally, there would be few companies conducting drilling campaigns of this scale, to this depth," BHP's leading geologist Michael Fonti said <a href="https://www.bnnbloomberg.ca/business/international/2024/09/19/a-copper-ma-frenzy-masks-big-miners-hesitation-to-build/">for</a> Bloomberg.
<h1 class="wp-block-heading">Buy, Don't Build</h1>
Yet, despite Oak Dam's promise, even BHP, the world&#8217;s largest mining company, focuses more on acquisitions than new developments. 
The company bought OZ Minerals for $6.4 billion while failing to complete a $49 billion acquisition of Anglo American, which owns significant copper assets in South America.
Still, BHP expanded its foothold on that continent by <a href="https://www.benzinga.com/markets/equities/24/07/40031488/bhp-to-unlock-south-american-copper-riches-partners-with-lundin-for-filo-acquisition">recently acquiring</a> the Filo copper project on the Argentina-Chile border in partnership with Lundin Mining.
The acquisition trend is evident across the industry, as rising costs, long permitting timelines and geopolitical uncertainties make greenfield exploration unattractive. Less than a quarter of mining projects approved between 2019 and 2023 were greenfield developments.
<h1 class="wp-block-heading">Digging Through the Past</h1>
The economics of new mining developments showcase the slowdown. The initial capital expenditures (capex) to build a mine have skyrocketed. 
For instance, the Dundee Precious Metals project in Serbia has an estimated capex of $381 million, a hefty price tag for a mine expected to produce just over 129,000 ounces of gold annually.
The cost per ton of copper production has exceeded $44,000 <a href="https://aheadoftheherd.com/copper-mines-becoming-more-capital-intensive-and-costly-to-run/">already in 2022</a> AOTH estimated, with projects such as Cobre Panama exemplifying this trend. Built at a capex of $6.7 billion, its production capacity started at 175,000 tons, yielding a capital intensity of $38,000 per ton — significantly higher than historical averages.
Moreover, many current copper deposits were discovered in the 20th century. Escondida, the world's largest copper mine, was found in the late 1970s, and most of the copper being mined today comes from that era.
"Everything being produced now is from that era of discoveries," BHP's Fonti pointed out.
<h1 class="wp-block-heading">AI-Powered Capex</h1>
Despite the problematic state of greenfield exploration, the latest technological advancements offer hope. Artificial intelligence (AI) can help comb through historical geological data, identifying opportunities a human eye might have missed. Even Oak Dam was nearly missed, as cutting-edge geophysical methods uncovered it.
Startups like KoBold Metals have gone AI from their inception, using advanced data analytics to target new deposits. Its high-profile investors include Bill Gates, Jeff Bezos and Jack Ma. The company might go public in the near future, with speculations about a <a href="https://www.benzinga.com/startups/24/08/40303146/the-next-big-thing-in-mining-bill-gates-kobold-metals-and-its-2-billion-valuation-goal">valuation of $2 billion</a>.
<h1 class="wp-block-heading">The External Factors</h1>
Growing geopolitical instability, driven by conflicts in Eastern Europe, Asia and Africa, can disrupt even the most promising projects.
Recent unrest in Pakistan is threatening to throw the country into deep political turmoil, with the newly minted government losing control over the disgruntled population grappling with an economic crisis, the New York Times <a href="https://www.nytimes.com/2024/08/01/world/asia/pakistan-protests-politics.html">wrote</a> last month. Large-scale protests were particularly notable in Balochistan, a province that houses one of the most notable copper projects, Barrick's Reko Diq $7 billion mine.
Meanwhile, a regulatory shift prompted the Panamanian government to close the Cobre Panama mine, a project that accounted for around 1.5% of the global copper supply. This action left a historical reminder that external factors can nullify years of exploration and billions in investments.
Read Next: • <a href="https://www.benzinga.com/news/24/09/40915786/barrick-forecasts-strong-organic-growth-by-2030-ceo-bristow-touts-undervaluation">Barrick Forecasts Strong Organic Growth By 2030, CEO Bristow Touts Undervaluation</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com" target="_blank" rel="noreferrer noopener">licensing@benzinga.com</a> to get started!
Photo: Shutterstock

Large Cap

Commodities

Global

Copper M&A Frenzy Masks Greenfield Exploration Weakness: Is AI To Blame?

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Columbia Banking System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.2, a high estimate of $29.00, and a low estimate of $22.00. Surpassing the previous average price target of $22.30, the current average has increased by 17.49%.
<img src="https://www.benzinga.com/files/images/story/2024/1726844437_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Columbia Banking System. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Steven Alexopoulos</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$29.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$29.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Andrew Terrell</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$26.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$27.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$24.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Steven Alexopoulos</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Columbia Banking System. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Columbia Banking System compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Columbia Banking System's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Columbia Banking System's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/COLB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Columbia Banking System analyst ratings.</a>
<h2>Unveiling the Story Behind Columbia Banking System</h2>
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
<h3>Columbia Banking System's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Columbia Banking System's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -9.83%. This indicates a decrease in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Columbia Banking System's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 25.45%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Columbia Banking System's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.42%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Columbia Banking System's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.23%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Columbia Banking System's debt-to-equity ratio stands notably higher than the industry average, reaching 0.89. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COLB

Evaluating Columbia Banking System: Insights From 10 Financial Analysts

Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) with a Neutral and maintains $395 price target.

Price Target

Reiteration

Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $395 Price Target

JP Morgan analyst John Ivankoe maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Overweight and raises the price target from $165 to $176.

JP Morgan Maintains Overweight on Darden Restaurants, Raises Price Target to $176

In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a comprehensive industry comparison, evaluating Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) against its key competitors in the Financial Services industry. By analyzing important financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>Visa Background</h3>
Visa is the largest payment processor in the world. In fiscal 2023, it processed almost $15 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Visa Inc</td>
<td>30.54</td>
<td>14.49</td>
<td>16.70</td>
<td>12.62%</td>
<td>$6.45</td>
<td>$7.13</td>
<td>9.57%</td>
</tr>
<tr>
<td>Mastercard Inc</td>
<td>37.69</td>
<td>61.37</td>
<td>17.50</td>
<td>44.44%</td>
<td>$4.32</td>
<td>$5.35</td>
<td>11.04%</td>
</tr>
<tr>
<td>Fiserv Inc</td>
<td>31.09</td>
<td>3.66</td>
<td>5.41</td>
<td>3.14%</td>
<td>$2.22</td>
<td>$3.12</td>
<td>7.38%</td>
</tr>
<tr>
<td>PayPal Holdings Inc</td>
<td>18.83</td>
<td>3.85</td>
<td>2.69</td>
<td>5.46%</td>
<td>$1.75</td>
<td>$3.61</td>
<td>8.21%</td>
</tr>
<tr>
<td>Fidelity National Information Services Inc</td>
<td>83.57</td>
<td>2.70</td>
<td>4.90</td>
<td>1.39%</td>
<td>$0.8</td>
<td>$0.95</td>
<td>2.68%</td>
</tr>
<tr>
<td>Block Inc</td>
<td>63.56</td>
<td>2.19</td>
<td>1.84</td>
<td>1.02%</td>
<td>$0.6</td>
<td>$2.23</td>
<td>11.21%</td>
</tr>
<tr>
<td>Global Payments Inc</td>
<td>20.73</td>
<td>1.28</td>
<td>2.95</td>
<td>1.68%</td>
<td>$1.08</td>
<td>$1.63</td>
<td>4.74%</td>
</tr>
<tr>
<td>Corpay Inc</td>
<td>22.73</td>
<td>7.90</td>
<td>6</td>
<td>8.38%</td>
<td>$0.51</td>
<td>$0.77</td>
<td>2.9%</td>
</tr>
<tr>
<td>Jack Henry &amp; Associates Inc</td>
<td>33.58</td>
<td>6.95</td>
<td>5.79</td>
<td>5.58%</td>
<td>$0.18</td>
<td>$0.23</td>
<td>4.73%</td>
</tr>
<tr>
<td>WEX Inc</td>
<td>35.64</td>
<td>4.75</td>
<td>3.33</td>
<td>4.32%</td>
<td>$0.25</td>
<td>$0.41</td>
<td>8.4%</td>
</tr>
<tr>
<td>Shift4 Payments Inc</td>
<td>52.05</td>
<td>8.19</td>
<td>1.91</td>
<td>5.7%</td>
<td>$0.13</td>
<td>$0.23</td>
<td>29.83%</td>
</tr>
<tr>
<td>Euronet Worldwide Inc</td>
<td>17.53</td>
<td>3.72</td>
<td>1.31</td>
<td>6.76%</td>
<td>$0.18</td>
<td>$0.41</td>
<td>5.02%</td>
</tr>
<tr>
<td>The Western Union Co</td>
<td>7.12</td>
<td>8.94</td>
<td>0.97</td>
<td>33.62%</td>
<td>$0.24</td>
<td>$0.4</td>
<td>-8.85%</td>
</tr>
<tr>
<td>StoneCo Ltd</td>
<td>11.42</td>
<td>1.37</td>
<td>1.76</td>
<td>3.29%</td>
<td>$1.13</td>
<td>$2.25</td>
<td>11.86%</td>
</tr>
<tr>
<td>PagSeguro Digital Ltd</td>
<td>8.95</td>
<td>1.17</td>
<td>1.80</td>
<td>3.59%</td>
<td>$1.83</td>
<td>$-0.02</td>
<td>6.74%</td>
</tr>
<tr>
<td>Payoneer Global Inc</td>
<td>29.15</td>
<td>4.32</td>
<td>3.24</td>
<td>4.87%</td>
<td>$0.06</td>
<td>$0.2</td>
<td>15.86%</td>
</tr>
<tr>
<td>Paymentus Holdings Inc</td>
<td>85.42</td>
<td>6.12</td>
<td>4.02</td>
<td>2.1%</td>
<td>$0.02</td>
<td>$0.06</td>
<td>32.55%</td>
</tr>
<tr>
<td>DLocal Ltd</td>
<td>19.57</td>
<td>5.54</td>
<td>3.69</td>
<td>10.06%</td>
<td>$0.06</td>
<td>$0.07</td>
<td>6.29%</td>
</tr>
<tr>
<td>Evertec Inc</td>
<td>32.30</td>
<td>4.49</td>
<td>2.85</td>
<td>6.44%</td>
<td>$0.09</td>
<td>$0.11</td>
<td>26.88%</td>
</tr>
<tr>
<td>Average</td>
<td>33.94</td>
<td>7.7</td>
<td>4.0</td>
<td>8.44%</td>
<td>$0.86</td>
<td>$1.22</td>
<td>10.41%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By closely examining Visa, we can identify the following trends: 
<ul>
<li>
With a Price to Earnings ratio of 30.54, which is 0.9x less than the industry average, the stock shows potential for growth at a reasonable price, making it an interesting consideration for market participants.
</li>
<li>
It could be trading at a premium in relation to its book value, as indicated by its Price to Book ratio of 14.49 which exceeds the industry average by 1.88x.
</li>
<li>
With a relatively high Price to Sales ratio of 16.7, which is 4.17x the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
The Return on Equity (ROE) of 12.62% is 4.18% above the industry average, highlighting efficient use of equity to generate profits.
</li>
<li>
Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $6.45 Billion, which is 7.5x above the industry average, indicating stronger profitability and robust cash flow generation.
</li>
<li>
The gross profit of $7.13 Billion is 5.84x above that of its industry, highlighting stronger profitability and higher earnings from its core operations.
</li>
<li>
The company is witnessing a substantial decline in revenue growth, with a rate of 9.57% compared to the industry average of 10.41%, which indicates a challenging sales environment.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726844429_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is a measure that indicates the level of debt a company has taken on relative to the value of its assets net of liabilities.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In terms of the Debt-to-Equity ratio, Visa stands in comparison with its top 4 peers, leading to the following comparisons:
<ul>
<li>
When comparing the debt-to-equity ratio, Visa is in a stronger financial position compared to its top 4 peers.
</li>
<li>
The company has a lower level of debt relative to its equity, indicating a more favorable balance between the two with a lower debt-to-equity ratio of 0.54.
</li>
</ul>
<h3>Key Takeaways</h3>
For Visa, the PE ratio is low compared to peers, indicating potential undervaluation. The high PB and PS ratios suggest strong market sentiment and revenue multiples. In terms of ROE, EBITDA, and gross profit, Visa demonstrates high profitability and operational efficiency. However, the low revenue growth may raise concerns about future performance compared to industry peers in the Financial Services sector.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comparing Visa With Industry Competitors In Financial Services Industry

In the preceding three months, 5 analysts have released ratings for Ameris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NYSE">ABCB</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Ameris, revealing an average target of $69.4, a high estimate of $76.00, and a low estimate of $64.00. This upward trend is apparent, with the current average reflecting a 17.23% increase from the previous average price target of $59.20.
<img src="https://www.benzinga.com/files/images/story/2024/1726844425_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Ameris among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$73.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$69.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Kevin Fitzsimmons</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$76.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Catherine Mealor</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Tyler Stafford</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$64.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ameris. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Ameris compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Ameris's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Ameris's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ABCB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ameris analyst ratings.</a>
<h2>Unveiling the Story Behind Ameris</h2>
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into five segments: banking, retail mortgage, warehouse lending, SBA, and premium finance. The company generates most of its revenue from the banking segment. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.
<h3>Financial Milestones: Ameris's Journey</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3 months period, Ameris showcased positive performance, achieving a revenue growth rate of 8.5% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Ameris's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 31.31% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Ameris's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.57% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Ameris's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.35%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.3, Ameris adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABCB

Expert Outlook: Ameris Through The Eyes Of 5 Analysts

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) has outperformed the market over the past 15 years by 4.89% on an annualized basis producing an average annual return of 16.71%. Currently, CACI International has a market capitalization of $10.92 billion. 
Buying $100 In CACI: If an investor had bought $100 of CACI stock 15 years ago, it would be worth $1,039.18 today based on a price of $489.61 for CACI at the time of writing.
<h3>CACI International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726844421_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACI

$100 Invested In This Stock 15 Years Ago Would Be Worth $1,000 Today

Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) has outperformed the market over the past 5 years by 20.62% on an annualized basis producing an average annual return of 34.53%. Currently, Dell Technologies has a market capitalization of $81.70 billion. 
Buying $1000 In DELL: If an investor had bought $1000 of DELL stock 5 years ago, it would be worth $4,345.25 today based on a price of $116.32 for DELL at the time of writing.
<h3>Dell Technologies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726844415_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DELL

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $4,300 Today

In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a comprehensive industry comparison, evaluating Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) against its key competitors in the Pharmaceuticals industry. By examining key financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>Eli Lilly Background</h3>
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eli Lilly and Co</td>
<td>112.69</td>
<td>60.75</td>
<td>21.25</td>
<td>22.5%</td>
<td>$4.12</td>
<td>$9.13</td>
<td>35.98%</td>
</tr>
<tr>
<td>Novo Nordisk AS</td>
<td>45.06</td>
<td>35.80</td>
<td>15.70</td>
<td>18.97%</td>
<td>$35.74</td>
<td>$57.79</td>
<td>25.34%</td>
</tr>
<tr>
<td>Johnson &amp; Johnson</td>
<td>24.93</td>
<td>5.55</td>
<td>4.68</td>
<td>6.62%</td>
<td>$7.8</td>
<td>$15.58</td>
<td>4.31%</td>
</tr>
<tr>
<td>Merck &amp; Co Inc</td>
<td>21.71</td>
<td>6.82</td>
<td>4.78</td>
<td>13.0%</td>
<td>$7.45</td>
<td>$12.37</td>
<td>7.16%</td>
</tr>
<tr>
<td>AstraZeneca PLC</td>
<td>38.30</td>
<td>6.19</td>
<td>5.02</td>
<td>5.01%</td>
<td>$4.12</td>
<td>$10.76</td>
<td>13.33%</td>
</tr>
<tr>
<td>Novartis AG</td>
<td>23.72</td>
<td>5.63</td>
<td>4.90</td>
<td>7.97%</td>
<td>$5.25</td>
<td>$9.7</td>
<td>9.6%</td>
</tr>
<tr>
<td>Sanofi SA</td>
<td>31.18</td>
<td>1.81</td>
<td>2.78</td>
<td>1.53%</td>
<td>$2.03</td>
<td>$7.97</td>
<td>6.53%</td>
</tr>
<tr>
<td>Zoetis Inc</td>
<td>37.89</td>
<td>17.63</td>
<td>9.95</td>
<td>12.45%</td>
<td>$0.97</td>
<td>$1.69</td>
<td>8.3%</td>
</tr>
<tr>
<td>GSK PLC</td>
<td>14.01</td>
<td>4.49</td>
<td>1.82</td>
<td>8.32%</td>
<td>$2.31</td>
<td>$5.76</td>
<td>9.84%</td>
</tr>
<tr>
<td>Takeda Pharmaceutical Co Ltd</td>
<td>45.13</td>
<td>0.86</td>
<td>1.52</td>
<td>1.26%</td>
<td>$388.51</td>
<td>$821.04</td>
<td>14.11%</td>
</tr>
<tr>
<td>Dr Reddy's Laboratories Ltd</td>
<td>19.69</td>
<td>3.71</td>
<td>3.79</td>
<td>4.84%</td>
<td>$21.72</td>
<td>$46.34</td>
<td>13.87%</td>
</tr>
<tr>
<td>Jazz Pharmaceuticals PLC</td>
<td>18.85</td>
<td>1.83</td>
<td>1.99</td>
<td>4.52%</td>
<td>$0.36</td>
<td>$0.91</td>
<td>6.95%</td>
</tr>
<tr>
<td>Organon &amp; Co</td>
<td>5.20</td>
<td>36.08</td>
<td>0.82</td>
<td>203.12%</td>
<td>$0.43</td>
<td>$0.94</td>
<td>-0.06%</td>
</tr>
<tr>
<td>Corcept Therapeutics Inc</td>
<td>36.21</td>
<td>7.17</td>
<td>7.96</td>
<td>6.14%</td>
<td>$0.04</td>
<td>$0.16</td>
<td>39.15%</td>
</tr>
<tr>
<td>Prestige Consumer Healthcare Inc</td>
<td>18.07</td>
<td>2.18</td>
<td>3.33</td>
<td>2.94%</td>
<td>$0.08</td>
<td>$0.15</td>
<td>-4.36%</td>
</tr>
<tr>
<td>Average</td>
<td>27.14</td>
<td>9.7</td>
<td>4.93</td>
<td>21.19%</td>
<td>$34.06</td>
<td>$70.8</td>
<td>11.0%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>Through a thorough examination of Eli Lilly, we can discern the following trends: 
<ul>
<li>
The Price to Earnings ratio of 112.69 for this company is 4.15x above the industry average, indicating a premium valuation associated with the stock.
</li>
<li>
With a Price to Book ratio of 60.75, which is 6.26x the industry average, Eli Lilly might be considered overvalued in terms of its book value, as it is trading at a higher multiple compared to its industry peers.
</li>
<li>
The stock's relatively high Price to Sales ratio of 21.25, surpassing the industry average by 4.31x, may indicate an aspect of overvaluation in terms of sales performance.
</li>
<li>
With a Return on Equity (ROE) of 22.5% that is 1.31% above the industry average, it appears that the company exhibits efficient use of equity to generate profits.
</li>
<li>
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $4.12 Billion is 0.12x below the industry average, suggesting potential lower profitability or financial challenges.
</li>
<li>
The gross profit of $9.13 Billion is 0.13x below that of its industry, suggesting potential lower revenue after accounting for production costs.
</li>
<li>
The company's revenue growth of 35.98% is notably higher compared to the industry average of 11.0%, showcasing exceptional sales performance and strong demand for its products or services.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726844413_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio gauges the extent to which a company has financed its operations through debt relative to equity.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
When comparing Eli Lilly with its top 4 peers based on the Debt-to-Equity ratio, the following insights can be observed:
<ul>
<li>
Compared to its top 4 peers, Eli Lilly has a moderate debt-to-equity ratio of 2.13, indicating a balanced financial structure.
</li>
<li>
This suggests that the company maintains a reasonable level of debt while also leveraging equity financing.
</li>
</ul>
<h3>Key Takeaways</h3>
For Eli Lilly, the PE, PB, and PS ratios are all high compared to its peers in the Pharmaceuticals industry, indicating potentially overvalued stock. On the other hand, Eli Lilly's high ROE and revenue growth suggest strong performance relative to industry standards. However, the low EBITDA and gross profit levels may raise concerns about the company's operational efficiency and profitability compared to its competitors in the sector.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry

Over the past 24 hours, Ethereum's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) price has risen 4.78% to $2,545.71. This continues its positive trend over the past week where it has experienced a 7.0% gain, moving from $2,372.96 to its current price. As it stands right now, the coin's all-time high is $4,878.26. 
The chart below compares the price movement and volatility for Ethereum over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1726844406_0.png" alt="price_chart" />
The trading volume for the coin has increased 96.0% over the past week, while the overall circulating supply of the coin has decreased 0.02%. The current market cap ranking for ETH is #2 at $306.76 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1726844406_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

$ETH

Ethereum Rises More Than 4% In 24 hours

Richtech Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RR#NASDAQ">RR</a>) shares are volatile Friday. The company launched a new, AI-powered beverage service robot and announced a distributor <a href="https://www.benzinga.com/pressreleases/24/09/g40951026/richtech-robotics-introduces-scorpion-an-ai-powered-single-arm-beverage-service-robot-and-announce">agreement for the robot on Thursday. </a>
The Details:
On Thursday, Richtech Robotics shares climbed more than 9% after the company launched Scorpion. Scorpion is an AI-powered single-arm beverage service robot that provides customized drink recommendations using NVIDIA AI technologies to support its cocktail and wine-tasting programs.
The company also announced a distributor agreement with Park 34 Liquor Store Inc., under which the distributor has agreed to sell a minimum of 500 Scorpion units over five years, followed by a minimum of 500 units annually.
Read Next:<a href="https://www.benzinga.com/news/earnings/24/09/40948948/homebuilder-lennar-reports-better-than-expected-q3-results-details"> Homebuilder Lennar Reports Better-Than-Expected Q3 Results: Details</a>
&#8220;We are focused on providing solutions that streamline operations, increase efficiency, and create cash flow for our clients. With that focus, we are proud to unveil Scorpion, sleek in design, agile in its offerings, and eye-catching for customers,&#8221; said Matt Casella, Richtech Robotics President.&nbsp;
&#8220;By incorporating NVIDIA technologies with our own capabilities, we are helping elevate the industry to a new standard of precision and service,&#8221; Casella added.&nbsp;
Richtech Robotics shares climbed in Friday&#8217;s premarket trading, but reversed lower just before the opening bell. The stock is moving on heavy volume, with more than 16 million shares already traded in the session, according to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>.
<h3 class="wp-block-heading">How To Buy RR Stock:</h3>
By now you're likely curious about how to participate in the market for Richtech Robotics &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
RR Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Richtech Robotics shares are down 12.3% at 81 cents at the time of publication Friday. 
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40944577/whats-going-on-with-bitcoin-miner-cleansparks-stock">What&#8217;s Going On With Bitcoin-Miner CleanSpark&#8217;s Stock?</a></li>
</ul>
Image: Courtesy of Richtech Robotics, Inc.

Penny Stocks

What's Going On With Richtech Robotics Stock?

Vornado Realty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vno#NYSE">VNO</a>), with Medline, recently announced an agreement to increase Medline&#39;s presence at THE MART by 110,000 square feet. The long-term lease agreement with Vornado will run until 2036.
This expansion positions Medline as one of the largest tenants at Vornado&#39;s 3.7-million-square-foot property in downtown Chicago. Medline is set to increase its office space in THE MART from 51,000 to 161,000 square feet, expanding to a single, contiguous area that will occupy the majority of the 12th floor.
Headquartered in Northfield, IL, Medline is the largest manufacturer of medical-surgical products in the healthcare sector, as well as a provider of supply chain services and clinical solutions partner. The company enhances clinical, financial and operational results across various care settings, including large healthcare systems, independent physician practices, to home health patients and their families.
<h2>About Vornado&#39;s THE MART</h2>
Encompassing two entire city blocks, THE MART is the home for Chicago&#39;s technological innovative companies. This 25-story building stands as the largest and most important center for design in North America, featuring more than 250 premier design showrooms that provide the latest resources for both residential and commercial markets.
In the second quarter of 2024, at THE MART, 32,000 square feet of space (all at share) was leased for an initial rent of $56.39 per square foot and a weighted average lease term of 7.2 years. The tenant improvements and leasing commissions were $7.86 per square foot per annum or 13.9% of the initial rent.
Per Glen Weiss, executive vice president and co-head of Real Estate at Vornado, &quot;With its prime location and unrivaled amenity program, THE MART aligns perfectly with Medline&#39;s needs and continues to be a major bright spot in the Chicago office market.&quot;
<h2>Wrapping Up</h2>
Vornado&#39;s focus on having assets in such a few select high-rent, high barrier-to-entry geographic markets and its diversified tenant base, including Medline, are expected to drive steady cash flows and fuel its growth over the long term.
Over the past three months, shares of this Zacks Rank #3 (Hold) company have gained 51.1%, outperforming the industry&#39;s growth of 19.7%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/f1/78527.jpg?v=1336445420" />
Image Source: Zacks Investment Research
<h2>Stocks to Consider</h2>
Some better-ranked stocks from the broader REIT sector are Crown Castle Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cci#NYSE">CCI</a>) and Four Corners Property Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcpt#NYSE">FCPT</a>), each carrying a Zacks Rank #2 (Buy) at present.
The Zacks Consensus Estimate for Crown Castle&#39;s 2024 funds from operation (FFO) per share has moved marginally northward over the past two months to $6.97.
The Zacks Consensus Estimate for Four Corners&#39; current-year FFO per share has been raised marginally over the past month to $1.73.
Note: Anything related to earnings presented in this write-up represent funds from operations (FFO), a widely used metric to gauge the performance of REITs.
<a href="https://www.zacks.com/stock/news/2338738/medline-to-expand-at-vornado-realty-s-the-mart-by-110-000-square-feet?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2338738">To read this article on Zacks.com click here.</a>

Mid Cap

REIT

Health Care

General

Real Estate

FCPT

Medline to Expand at Vornado Realty's THE MART by 110,000 Square Feet

DA Davidson analyst Peter Heckmann maintains SS&amp;C Techs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) with a Buy and raises the price target from $88 to $92.

SSNC

DA Davidson Maintains Buy on SS&C Techs Hldgs, Raises Price Target to $92

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAT#NASDAQ">HCAT</a>) with a Overweight and maintains $16 price target.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

GBX Intl Gr

News

Latest news for GBX Intl Gr (OTC:GBXI) Stock